Ceftriaxone-Induced Toxic Hepatitis
| dc.authorscopusid | 26025132600 | |
| dc.authorscopusid | 28567567100 | |
| dc.authorscopusid | 14526773500 | |
| dc.authorwosid | Cagan, Eren/Hji-2036-2023 | |
| dc.contributor.author | Peker, Erdal | |
| dc.contributor.author | Cagan, Eren | |
| dc.contributor.author | Dogan, Murat | |
| dc.date.accessioned | 2025-05-10T17:19:41Z | |
| dc.date.available | 2025-05-10T17:19:41Z | |
| dc.date.issued | 2009 | |
| dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
| dc.department-temp | [Peker, Erdal; Cagan, Eren; Dogan, Murat] Med Univ Yuzuncu Yil, Dept Pediat, TR-65100 Van, Turkey | en_US |
| dc.description.abstract | Toxic hepatitis or drug-induced liver injury encompasses a spectrum of clinical disease ranging from mild biochemical abnormalities to acute liver failure. The advantages of along half-life, wide spectrum, high tissue penetration rate, and a good safety profile, make ceftriaxone, a third-generation cephalosporin, a frequent choice in the treatment of childhood infections. Previous studies have reported a few cases of high aspartate aminotransferase and alanine aminotransferase levels, along with three cases of hepatitis caused by ceftriaxone. Here, we report a case of drug-induced toxic hepatitis in a patient who was treated with ceftriaxone for acute tonsillitis. (C) 2009 The WJG Press and Baishideng. All rights reserved. | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded | |
| dc.identifier.doi | 10.3748/wjg.15.2669 | |
| dc.identifier.endpage | 2671 | en_US |
| dc.identifier.issn | 1007-9327 | |
| dc.identifier.issn | 2219-2840 | |
| dc.identifier.issue | 21 | en_US |
| dc.identifier.pmid | 19496200 | |
| dc.identifier.scopus | 2-s2.0-67651159076 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 2669 | en_US |
| dc.identifier.uri | https://doi.org/10.3748/wjg.15.2669 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14720/9880 | |
| dc.identifier.volume | 15 | en_US |
| dc.identifier.wos | WOS:000266786300017 | |
| dc.identifier.wosquality | Q2 | |
| dc.language.iso | en | en_US |
| dc.publisher | Baishideng Publishing Group inc | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Hepatitis | en_US |
| dc.subject | Toxic | en_US |
| dc.subject | Ceftriaxone | en_US |
| dc.subject | Children | en_US |
| dc.subject | Drug | en_US |
| dc.title | Ceftriaxone-Induced Toxic Hepatitis | en_US |
| dc.type | Article | en_US |